Molecular characterization of Echinocandin resistance and the CHS3-mediated adaptive response in Candida glabrata bloodstream infections in Eastern China

Aslam S, Rotstein C. AST Infectious Disease Community of Practice. Candida infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13623.

PubMed  Google Scholar 

Mazzanti S, Brescini L, Morroni G, Orsetti E, Pocognoli A, Donati A, et al. Candidemia in intensive care units over nine years at a large Italian university hospital: comparison with other wards. PLoS One. 2021;16:e0252165.

PubMed  PubMed Central  Google Scholar 

McCort ME, Tsai H. Epidemiology of invasive candidiasis in patients with hematologic malignancy on antifungal prophylaxis. Mycopathologia. 2023;188:885–92.

PubMed  Google Scholar 

Xiao M, Chen SCA, Kong F, Xu XL, Yan L, Kong HS, et al. Distribution and antifungal susceptibility of candida species causing candidemia in China: an update from the CHIF-NET study. J Infect Dis. 2020;221:S139-47.

PubMed  Google Scholar 

Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. Twenty years of the SENTRY antifungal surveillance program: results for candida species from 1997–2016. Open Forum Infect Dis. 2019;6:S79-94.

PubMed  PubMed Central  Google Scholar 

Carbia M, Medina V, Bustillo C, Martínez C, González MP, Ballesté R. Study of candidemia and its antifungal susceptibility profile at the University Hospital of Montevideo. Uruguay Mycopathologia. 2023;188:919–28.

PubMed  Google Scholar 

McCarty TP, White CM, Pappas PG. Candidemia and invasive candidiasis. Infect Dis Clin North Am. 2021;35:389–413.

PubMed  Google Scholar 

Martínez-Herrera E, Frías-De-León MG, Hernández-Castro R, García-Salazar E, Arenas R, Ocharan-Hernández E, et al. Antifungal resistance in clinical isolates of Candida glabrata in Ibero-America. J Fungi (Basel). 2021;8:14.

PubMed  PubMed Central  Google Scholar 

Hu C, Fong G, Wurster S, Kontoyiannis DP, Beyda ND. Clumping morphology influences virulence uncoupled from echinocandin resistance in Candida glabrata. Microbiol Spectr. 2022;10:e0183721.

PubMed  Google Scholar 

Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019;25:792–8.

PubMed  Google Scholar 

Won EJ, Choi MJ, Kim M-N, Yong D, Lee WG, Uh Y, et al. Fluconazole-resistant Candida glabrata bloodstream isolates, South Korea, 2008–2018. Emerg Infect Dis. 2021;27:779.

PubMed  PubMed Central  Google Scholar 

Szymański M, Chmielewska S, Czyżewska U, Malinowska M, Tylicki A. Echinocandins– structure, mechanism of action and use in antifungal therapy. J Enzyme Inhibit Med Chem. 2022;37:876–94.

Google Scholar 

Han Q, Wang N, Yao G, Mu C, Wang Y, Sang J. Blocking β-1,6-glucan synthesis by deleting KRE6 and SKN1 attenuates the virulence of Candida albicans. Mol Microbiol. 2019;111:604–20.

PubMed  Google Scholar 

Lott TJ, Frade JP, Lockhart SR. Multilocus sequence type analysis reveals both clonality and recombination in populations of Candida glabrata bloodstream isolates from U.S. surveillance studies. Eukaryot Cell. 2010;9:619–25.

PubMed  PubMed Central  Google Scholar 

Huang Y-T, Liu C-Y, Liao C-H, Chung K-P, Sheng W-H, Hsueh P-R. Antifungal susceptibilities of candida isolates causing bloodstream infections at a medical center in Taiwan, 2009–2010. Antimicrob Agents Chemother. 2014;58:3814–9.

PubMed  PubMed Central  Google Scholar 

Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106.

PubMed  PubMed Central  Google Scholar 

Li Q, Skinner J, Bennett JE. Evaluation of reference genes for real-time quantitative PCR studies in Candida glabrata following azole treatment. BMC Mol Biol. 2012;13:22.

PubMed  PubMed Central  Google Scholar 

Atiencia-Carrera MB, Cabezas-Mera FS, Tejera E, Machado A. Prevalence of biofilms in Candida spp. bloodstream infections: a meta-analysis. PLoS One. 2022;17:e0263522.

PubMed  PubMed Central  Google Scholar 

Chen L, Xie Z, Jian J. Epidemiology and risk factors of candidemia a 8-year retrospective study from a teaching hospital in China. Infect Drug Resist. 2024;17:3415–23.

PubMed  PubMed Central  Google Scholar 

Li Y, Gu C, Yang Y, Ding Y, Ye C, Tang M, et al. Epidemiology, antifungal susceptibility, risk factors, and mortality of persistent candidemia in adult patients in China: a 6-year multicenter retrospective study. BMC Infect Dis. 2023;23:369.

PubMed  PubMed Central  Google Scholar 

Al-Hasan MN, Rac H. Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections. Clin Microbiol Infect. 2020;26:299–306.

PubMed  Google Scholar 

Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024;24:e428-38.

PubMed  Google Scholar 

Xiao M, Sun Z, Kang M, Guo D,, Chen SC, et al. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol. 2018;56:577–618.

Gabaldón T, Gómez-Molero E, Bader O. Molecular typing of Candida glabrata. Mycopathologia. 2020;185:755–64.

PubMed  Google Scholar 

Dendani Chadi Z, Dib L, Zeroual F, Benakhla A. Usefulness of molecular typing methods for epidemiological and evolutionary studies of Staphylococcus aureus isolated from bovine intramammary infections. Saudi J Biol Sci. 2022;29:103338.

PubMed  PubMed Central  Google Scholar 

Canela HMS, Cardoso B, Frazão MR, Falcão JP, Vitali LH, Martinez R, et al. Genetic diversity assessed using PFGE, MLP and MLST in Candida spp. candidemia isolates obtained from a Brazilian hospital. Braz J Microbiol. 2021;52:503–16.

PubMed  PubMed Central  Google Scholar 

Li Y, Hou X, Li R, Liao K, Ma L, Wang X, et al. Whole genome analysis of echinocandin non-susceptible Candida glabrata clinical isolates: a multi-center study in China. BMC Microbiol. 2023;23:341.

PubMed  PubMed Central  Google Scholar 

Hou X, Xiao M, Chen SC-A, Kong F, Wang H, Chu Y-Z, et al. Molecular epidemiology and antifungal susceptibility of Candida glabrata in China (August 2009 to July 2014): a multi-center study. Front Microbiol. 2009;2017(8):880.

Google Scholar 

Byun SA, Won EJ, Kim M-N, Lee WG, Lee K, Lee HS, et al. Multilocus sequence typing (MLST) genotypes of Candida glabrata bloodstream isolates in Korea: association with antifungal resistance, mutations in mismatch repair gene (Msh2), and clinical outcomes. Front Microbiol. 2018;9:1523.

PubMed  PubMed Central  Google Scholar 

Amanloo S, Shams-Ghahfarokhi M, Ghahri M, Razzaghi-Abyaneh M. Genotyping of clinical isolates of Candida glabrata from Iran by multilocus sequence typing and determination of population structure and drug resistance profile. Med Mycol. 2018;56:207–15.

PubMed  Google Scholar 

Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z. Molecular fingerprinting by multi-locus sequence typing identifies microevolution and nosocomial transmission of Candida glabrata in Kuwait. Front Public Health. 2023;11:1242622.

PubMed  PubMed Central  Google Scholar 

Dodgson AR, Pujol C, Denning DW, Soll DR, Fox AJ. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol. 2003;41:5709–17.

PubMed  PubMed Central  Google Scholar 

Xiao M, Sun ZY, Kang M, Guo DW, Liao K, Chen SCA, et al. Five-year national surveillance of invasive candidiasis: species distribution and azole susceptibility from the China hospital invasive fungal surveillance net (CHIF-NET) study. J Clin Microbiol. 2018;56:e00577-18.

PubMed  PubMed Central  Google Scholar 

Chesdachai S, Yetmar ZA, Ranganath N, Everson JJ, Wengenack NL, Abu Saleh OM. Antifungal susceptibility pattern of Candida glabrata from a referral center and reference laboratory: 2012–2022. J Fungi (Basel). 2023;9:821.

PubMed  PubMed Central  Google Scholar 

Dellière S, Healey K, Gits-Muselli M, Carrara B, Barbaro A, Guigue N, et al. Fluconazole and echinocandin resistance of Candida glabrata correlates better with antifungal drug exposure rather than with MSH2 mutator genotype in a French cohort of patients harboring low rates of resistance. Front Microbiol. 2016;7:2038.

PubMed  PubMed Central  Google Scholar 

Chen Y, Wu Y, Lulou K, Yao D, Ying C. Multilocus sequence typing and antifungal susceptibility of vaginal and non-vaginal Candida glabrata isolates from China. Front Microbiol. 2022;13:808890.

PubMed  PubMed Central  Google Scholar 

Mushi MF, Gross U, Mshana SE, Bader O. High diversity of Candida glabrata in a tertiary hospital-Mwanza. Tanzania Med Mycol. 2019;57:914–7.

PubMed  Google Scholar 

Víglaš J, Olejníková P. Signalling mechanisms involved in stress response to antifungal drugs. Res Microbiol. 2021;172:103786.

PubMed  Google Scholar 

Mio T, Yabe T, Sudoh M, Satoh Y, Nakajima T, Arisawa M, et al. Role of three chitin synthase genes in the growth of Candida albicans. J Bacteriol. 1996;178:2416–9.

PubMed  PubMed Central  Google Scholar 

Banda-Flores IA, Torres-Tirado D, Mora-Montes HM, Pérez-Flores G, Pérez-García LA. Resilience in resistance: the role of cell wall integrity in multidrug-resistant Candida. J Fungi. 2025;11:271.

Google Scholar 

Bowman SM, Free SJ. The structure and synthesis of the fungal cell wall. Bioessays. 2006;28:799–808.

PubMed  Google Scholar 

Walker LA, Gow NAR, Munro CA. Fungal echinocandin resistance. Fungal Genet Biol. 2010;47:117–26.

Comments (0)

No login
gif